During the past decade, IKP GmbH conducted 0 clinical trials. In the 10-year time frame, 0 clinical trials started and 0 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

According to Clinical.Site data, the most researched conditions in "IKP GmbH" are "Smoking Cessation" (3 trials). Many other conditions were trialed in "IKP GmbH" in a lesser frequency.

Most popular intervention types in "IKP GmbH" are "Drug" (3 trials) and "Radiation" (1 trials). Other intervention types were less common.

The name of intervention was led by "Nicotine Patch" (3 trials), "Placebo Patch" (3 trials), "No Patch Control" (1 trials), "SLS Comparator Patch" (1 trials) and "UVA and UVB irradiation" (1 trials). Other intervention names were less common.

The vast majority of trials in "IKP GmbH" are 3 trials for "All" genders.

Currently, there are NaN active trials in "IKP GmbH". undefined are not yet recruiting, undefined are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 3 completed trials in IKP GmbH, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in IKP GmbH, 3 "Phase 1" clinical trials were conducted, 0 "Phase 2" clinical trials and 0 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".